Science & Education

The Science Behind
Retatrutide

Understand exactly how the world's most advanced weight-loss peptide works — the clinical trial data, the metabolic pathways, and what leading scientists say about it.

Start Your Assessment View Clinical Data
28.7%
Avg. weight loss
at 68 weeks
90%+
Patients achieving
10%+ weight loss
80%+
Liver fat
reduction
3×
Metabolic pathways
targeted
Proven Results

The Clinical Trial Data
(Phase 2 & 3)

Published results from peer-reviewed trials and the landmark TRIUMPH-4 Phase 3 study — the largest clinical dataset ever recorded for an obesity drug.

Metric Result
Weight loss at 48 weeks (12mg dose) Up to 24% average body weight reduction
Weight loss at 68 weeks (Phase 3 TRIUMPH-4) 28.7% average — highest ever recorded for an obesity drug
Liver fat reduction Over 80% liver fat reduction at 8–12mg doses
Lean mass preservation Fat mass cut by 26% at 8mg; lean mass largely preserved
Patients achieving 10%+ weight loss Over 90% of participants
Source: New England Journal of Medicine, Phase 2 Trial (2023) + Eli Lilly TRIUMPH-4 Phase 3 results (December 2025)
How It Works

A New Generation of Metabolic Science

Retatrutide is part of a new class of peptides designed to interact with three metabolic signalling pathways simultaneously. This triple-agonist approach is why scientists consider it one of the most exciting metabolic research developments in years.

GLP-1 Pathway

Helps control hunger and keeps you feeling full longer after eating. Slows gastric emptying and increases satiety signalling in the brain.

GIP Pathway

Helps your body use food more efficiently for energy instead of storing it as fat. Enhances insulin secretion from the pancreas and improves glucose uptake.

Glucagon Pathway

Helps your body burn more fat and use more energy throughout the day. Activates glucagon receptors in the liver to increase metabolic rate and energy expenditure.

Mechanism of Action

Metabolic Pathways:
The Incretin Axis & Glucagon

How Retatrutide simultaneously activates three receptor systems to produce its remarkable clinical results.

GLP-1

Glucagon-like peptide-1

▼
GLP-1
RECEPTORS
Satiety
Increases ↑ · Slows
Gastric Emptying
Insulin ↑ · Glucagon ↓

GIP

Glucose-dependent insulinotropic polypeptide

▼
GIP
RECEPTORS
Pancreas
Insulin Secretion ↑
Intestines
Glucose Absorption ↑

Glucagon

 

▼
GLUCAGON
RECEPTORS
Liver
Glycogenolysis ↑ · Gluconeogenesis ↑
Blood Glucose Output
Increases ↑
Pancreas ↑ Insulin ↑ →
GLU
COSE
→ Glucagon ↓ Liver ↑

Glucose Homeostasis

Expert Opinions

What the World's Leading Scientists
Say About Retatrutide

Dr. Peter Attia
"

"Retatrutide is one of the most promising new compounds in the pipeline — the data is remarkable."

Dr. Peter Attia
MD, Stanford/Johns Hopkins · 100M+ podcast
Ben Greenfield
"

"Retatrutide gives me the metabolic effects of an impressive peptide without wrecking my appetite or my gains."

Ben Greenfield
Biohacker · Author · Ironman Triathlete
Dr. Lee M. Kaplan
"

"Stunning — the first triple-hormone combination highly effective for not only weight loss but liver disease and diabetes."

Dr. Lee M. Kaplan
MD — Director, Obesity & Nutrition Institute
Ready to Start?

Take the next step towards
your weight-loss journey

Complete a short medical questionnaire and our team will match you with the right Retatrutide protocol.

Start Your Free Assessment

Takes 3 minutes · No commitment · Free consultation